Nonclassical and endogenous cannabinoids: Effects on the ordering of brain membranes

Neurochemical Research

Volumn 22, Issue 5, 1997, Pages 563-568

  Bloom, A S ^a   Edgemond, W S ^a   Moldvan, J C ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

anandamide; Cannabinoids; fluorescence polarization; membrane order

Indexed keywords

ANANDAMIDE; CANNABINOID DERIVATIVE; DRONABINOL;

ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; FLUORESCENCE POLARIZATION; LIPID ANALYSIS; LIPID MEMBRANE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOSPECIFICITY; SYNAPTIC MEMBRANE;

ANIMALIA;

EID: 0030998073     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022413901857     Document Type: Article

References (33)

1. Pertwee, R. 1993. The evidence for the existence of cannabinoid receptors. Gen. Pharmac. 24:811-824.
2. Howlett, A. C., Johnson, M. R., Melvin, L. S., and Milne, G. M. 1988. Nonclassical cannabinol analgetics inhibit adenylate cyclase: Development of a cannabinoid receptor model. Mol. Pharmacol. 33:297-302.
3. Herkenham, M., Lynn, A. B., Little M. D., Johnson, M. R., Melvin, L. S., De Costa, B. R., and Rice, K. C. 1990. Cannabinoid receptor localization in the brain. Proc. Natl. Acad. Sci. USA 87: 1932-6.
4. Devane, W. A., Dysarz III, F. A., Johnson, M. R., Melvin, L. S., and Howlett, A. C. 1988. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34:605-613.
5. Felder, C. C., Veluz, J. S., Williams, H. L., Briley, E. M., and Matsuda, L. A. 1992. Cannabinoid agonists stimulate both receptor- and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42:838-845.
6. Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., and Devane, W. A. 1993. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 90:7656-7660.
7. Dewey, W. 1986. Cannabinoid pharmacology. Pharmacol. Rev. 38:151-178.
8. Pertwee, R. G. 1988. The central neuropharmacology of psychotropic cannabinoids. Pharmac. Ther. 36:189-261.
9. Hillard, C. J., Harris, R. A., and Bloom, A. S. 1985. Effects of the cannabinoids on the physical properties of brain membranes and phospholipid vesicles: Fluorescence studies. J. Pharmacol. Exp. Ther. 232:579-588.
10. Bruggemann, E. P., and Melchoir, D. L. 1983. Alterations in the organization of phosphatidylcholine/cholesterol bilayers by tetrahydrocannabinol. 258:8298-8303.
11. Gill, E. W., and Lawrence, D. K. 1976. The physiochemical mode of action of tetrahydrocannabinol on cell membranes. Pages 147-55, in Braude, M. C. and Szara, S. (eds.), The Pharmacology of Marijuana, Raven Press, New York.
12. 1-tetrahydrocannabinol into erythrocyte membranes in vivo and its effects on membrane fluidity. Experientia 40:866-867.
13. Makriyannis, A., and Rapaka, R. S. 1990. The molecular basis of cannabinoid activity. Life Sci. 47:2173-2184.
14. Tamir, I., and Lichtenberg, D. 1983. Correlation between the psychotropic potency of cannabinoids and their effect on the H-NMR spectra of model membranes. J. Pharmac. Sci. 72:458-461.
15. Martin, B. R. 1986. Cellular effects of the cannabinoids. Pharmacol. Rev. 38:45-74.
16. 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes. Biochem. Pharmacol. 35:2797-2803.
17. 9-tetrahydrocannabinol on adenylate cyclase activation in heart. J. Pharmacol. Exp. Ther. 252:1075-1082.
18. Thomas, B. F., Compton, D. R., and Martin, B. R. 1990. Characterization of the lipophilicity of natural and synthetic analogs of delta-9-tetrahydrocannabinol and its relationship to pharmacological potency. J. Pharmacol. Exp. Ther. 255:624-630.
19. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
20. Fride, E., and Mechoulam, R. 1993. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231:313-314.
21. Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E., and Mechoulam, R. 1993. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61:352-355.
22. Lentz, B. 1989. Membrane "fluidity" as detected by diphenyIhexatriene probes. Chemistry and Physics of Lipids 50:171-190.
23. van Blitterswijk, W. J., van Hoeven, R. P., and van der Meer, B. W. 1981. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim. Biophys. Acta 644:323-332.
24. Cotman, C. W., and Matthews, D. A. 1971. Synaptic plasma membranes from rat brain synaptosomes: Isolation and partial characterization. Biochim. Biophys. Acta 249:380-394.
25. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:248-252.
26. Bloom, A. S., and Hillard, C. J. 1984. Cannabinoids, neurotransmitter receptors and brain membranes. Pages 217-231, in D. J. Harvey, W. Paton and G. G. Nahas (Eds.), Marihuana '84, IRL Press Limited, Oxford, England.
27. 2H-NMR. Biochim. Biophys. Acta 1103:25-36.
28. Hollister, L. E. 1986. Health aspects of cannabis. Pharmacol. Rev. 38:1-20.
29. Browne, R. G., Ph.D., and Weissman, A. P. 1981. Discriminative stimulus properties of A9-tetrahydrocannabinol: Mechanistic studies. J. Clin. Pharmacol. 21:227S-234S.
30. Compton, D. R., Johnson, M. R., Melvin, L. S., and Martin, B. R. 1992. Pharmacological profile of a series of bicyclic cannabinoid analogs: Classification as cannabimimetic agents. J. Pharmacol. Exp. Ther. 260:201-208.
31. Pacheco, M., Childers, S. R., Arnold, R., Casiano, F., and Ward, S. J. 1991. Aminoalkylindoles: Actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257:170-183.
32. Houslay, M. D., and Stanley, K. K. 1982. Dynamics of Biological Membranes. John Wiley and Sons, Chichester.
33. Howlett, A. C. 1985. Cannabinoid inhibition of adenylate cyclase: Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27:429-436.